Avita Medical | 1811094D - 贸易债权人

股票价格
1.30
每天变化
0.10 8.33%
每月一次
-5.11%
每年
-52.90%
Q2 预测
1.05


金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 171.18M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


贸易债权人 更改 日
Accuray USD 42.4M 8.37M 2025-09
Celltrion KRW 104.19B 15.67B 2025-09
Clinuvel Pharmaceuticals AUD 10.68M 731.35K 2025-12
Cochlear AUD 281.3M 17.1M 2025-12
CSL USD 3.17B 290M 2025-12
Cspc Pharmaceutical CNY 2.32B 236.83M 2025-12
Deva Holding AS TRY 809.81M 105.88M 2023-09
Dianthus Therapeutics USD 9.72M 3.02M 2025-12
Divis Laboratories Ltd INR 10.4B 1.3B 2025-09
Kangmei Pharma CNY 2.61B 176.42M 2025-09
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Laboratorios Farma EUR 107.59M 341K 2023-12
Malin Corporation EUR 700K 200K 2024-12
Mayne Pharma AUD 30.25M 2.99M 2025-06
Medical Developments International AUD 4.31M 2.18M 2025-12
Nanosonics AUD 12.22M 10.69M 2025-12
Neuren Pharmaceuticals AUD 2.4M 4.26M 2025-12
Organigram Holdings CAD 71.08M 18.17M 2025-12
Ovoca Bio EUR 186K 23K 2025-06
Pacific Edge NZD 5.45M 2.6M 2025-12
Paradigm Biopharmaceuticals AUD 4.44M 1.71M 2025-12
Pharma Mar EUR 54.34M 10.54M 2025-12
Polynovo AUD 4.9M 2.04M 2025-12
PYC Therapeutics AUD 9.56M 802.76K 2025-12
Qiagen NV USD 72.66M 2.11M 2025-12
Ramsay Health Care AUD 2.02B 289.9M 2025-12
ResMed USD 250.41M 16.36M 2025-12
Sartorius EUR 323.2M 61M 2025-09
Sino Biopharmaceutical CNY 2.82B 1.32B 2025-06
Telix Pharmaceuticals AUD 71.66M 19.98M 2025-12
Tilray USD 114.5M 3.69M 2025-09
Zealand Pharma A/S 346.6M 102.71M 2025-12
Zz Pientze Pharmaceu CNY 516.14M 31.53M 2025-09